Comparative evaluation of two colorectal cancer screening campaigns using different faecal occult blood tests in a French area. (December 2020)

• Record Type: Journal Article
• Authors: Cariou, Mélanie; El Fettouhi, Abdessamad; Kermarrec, Tiphaine; Bommelaere, Françoise; Foll, Yvon; Nousbaum, Jean-Baptiste; Robaszkiewicz, Michel; Quénéhervé, Lucille
• Is Part Of: Cancer epidemiology. Volume 69(2020:Dec.)
• Publication Date: 2020-12
• Subjects: AA advanced adenomas -- ADR adenoma detection rate -- C campaign -- CI confidence intervals -- CRC colorectal cancer -- FIT fecal immunological test -- FOBT fecal occult blood test -- NA non-analysable -- NAA non-advanced adenomas -- PPV positive predictive value; Colorectal cancer -- Screening -- Early detection -- Advanced adenomas -- Faecal immunological test -- Guaiac-based faecal occult blood test -- Adenoma detection rate -- Positive predictive value -- Time to colonoscopy; Cancer -- Epidemiology -- Periodicals; Cancer -- Prevention -- Periodicals; Cancer -- Diagnosis -- Periodicals; Carcinogenesis -- Periodicals; 616.994005
• DOI: 10.1016/j.canep.2020.101839
• Languages: English
• ISSNs: 1877-7821

Abstract

Highlights: CRC's detection rate increased significantly from 1.4 ‰ to 2.9 ‰ between C1 and C7. The advanced adenoma detection rate increased significantly from 5.7 ‰ to 13.7 ‰. 1.76 times more cancers, 2.06 times more advanced adenomas were detected with FIT. The time to colonoscopy had no impact on the stage of CRC at diagnosis. Abstract: Objective: The aim of this study was to compare quality performance of the first colorectal cancer (CRC) screening campaigns (C) with the OC Sensor® Faecal Immunological Test (FIT) (C7 from 2016 to 2017) and the Hemoccult® guaiac-based test (C1 from 2004 to 2006). Methods: The participation rate of the eligible population, screening fecal occult blood test (FOBT) performance indices, CRC and adenoma detection rate and time interval between test positivity and colonoscopy were studied. Results: In C7, 35.9 % of the eligible population completed the screening process versus 47.6 % in C1 (p < 0.0001). The positivity rate was of 4.3 % for OC Sensor® FIT and 2.3 % for Hemoccult® test (p < 0.0001). A total of 3, 252 colonoscopies were performed in C7 versus 2, 005 in C1; 246 CRCs and 1, 160 advanced adenomas (AA) were detected in C7 compared to 140 CRCs and 491 AA in C1 (p < 0.0001). The FOBT cancer detection rate increased significantly from 1.4 ‰ to 2.9 ‰ between the two campaigns, as did the FOBT AA detection rate, from 5.7 ‰ to 13.7 ‰. During C7, the mean time for colonoscopy after a positive FIT result was 84.3 days [95 % CI: 77.9–90.7]. There was no significant difference between the stages at diagnosis according to the time for colonoscopy within the first 6 months. Conclusions: CRC and AA detection rates increased significantly between the two campaigns. Longer follow-up will be required to show a potential decrease in the incidence of invasive CRCs.